75
2
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37207L |
Cdk5 Substrate acetate
|
CDK | Cell Cycle/Checkpoint |
Cdk5 Substrate acetate 是一种丝氨酸/苏氨酸激酶,主要在神经元组织中具有活性。与 p25 或 p35 一起,Cdk5 磷酸化一系列蛋白质,包括组蛋白 H1 和 tau。 它是一种合成肽 (PKTPKKAKKL),对应于组蛋白 H1 的序列。它被 Cdk5 磷酸化,Km 值为 5 µM。 | |||
T37207 |
Cdk5 Substrate
Cdk5 Substrate |
||
Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that is predominantly active in neuronal tissues. With p25 or p35, Cdk5 phosphorylates a range of proteins, including histone H1 and tau. Cdk5 substrate is a synthetic peptide (PKTPKKAKKL) corresponding to a sequence of histone H1. It is phosphorylated by Cdk5 with a Km value of 5 μM. | |||
T40263 |
CDK5-IN-1
CDK5-IN-1 |
||
CDK5-IN-1 is a highly potent inhibitor of CDK5, displaying an inhibitory activity of less than 10 nM. This potent compound is specifically employed in scientific investigations relating to kidney diseases. | |||
T36742 |
CDK5 inhibitor 20-223
CDK5 inhibitor 20-223 |
||
CDK5 inhibitor 20-223, a potent inhibitor of CDK2 and CDK5, demonstrates IC50 values of 6.0 nM and 8.8 nM, respectively. It serves as an effective agent against colorectal cancer (CRC)[1]. | |||
T35555 |
GSK-3/CDK5/CDK2-IN-1
GSK-3/CDK5/CDK2-IN-1 |
||
GSK-3/CDK5/CDK2-IN-1 is an imidazole derivative compound that inhibits cdk5, cdk2, and GSK-3.it has demonstrated applications in cancer research and the study of neurodegenerative diseases [1]. | |||
TP1602 |
[pThr3]-CDK5 Substrate
|
||
[pThr3]-CDK5 Substrate is an effective Phospho-Thr3CDK5 Substrate.[pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 µM[1]. | |||
TP1660 |
[pThr3]-CDK5 Substrate (TFA)
|
||
[pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 µM. | |||
T63184 | CDK5-IN-2 | ||
CDK5-IN-2 (compound 15) 是一种高选择性的 CDK5 抑制剂,能够作用于 CDK5/p25 (IC50: 0.2 nM) 和 CDK2/CycA (IC50: 23 nM)。 | |||
T76031 |
[pThr3]-CDK5 Substrate TFA
|
||
[pThr3]-CDK5 Substrate TFA 是 Thr3 磷酸化的CDK5底物。[pThr3]-CDK5 Substrate 来自组蛋白 H1,位于组蛋白 H1 上和CDK5作用的位点。CDK5Substrate 被CDK5磷酸化为 [pThr3]-CDK5 Substrate 的 Km 为 6 μM。 | |||
T61362 |
CDK5-IN-3
|
||
CDK5-IN-3 (compound 11) is a highly potent and selective inhibitor of CDK5, demonstrating significant inhibition with IC50 values of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. This compound holds promise for further investigation in the context of autosomal dominant polycystic kidney disease (ADPKD) research [1]. | |||
T7426 |
ALSTERPAULLONE
|
Apoptosis; GSK-3; CDK | Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
Alsterpaullone 是高效的 CDK 抑制剂,是一种 ATP 竞争性的 GSK-3alpha/GSK-3beta 抑制剂,且作用的 IC50值都为 4 nM。它有用于神经退行性和增生性疾病的研究潜力,具有抗肿瘤活性,诱导白血病细胞凋亡。 | |||
T7167 |
Purvalanol B
NG 95,(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇 |
CDK; Parasite | Cell Cycle/Checkpoint; Microbiology/Virology |
Purvalanol B (NG 95) 是选择性可逆的 ATP 竞争性 CDK 抑制剂。它在一系列其他蛋白激酶 (IC50>1000 nM) 中显示出对 CDK 的选择性。它抑制耐氯喹菌株 P. falciparum 的生长。 | |||
T8230 |
PNU112455A hydrochloride
PNU 112455A |
CDK | Cell Cycle/Checkpoint |
PNU112455A hydrochloride 是 CDK2 和 CDK5 的 ATP 位点竞争性抑制剂,与 CDK2 和 CDK5 的 ATP 位点结合,Km 值为 3.6 和 3.2 μM。 | |||
TQ0068 |
NVP-LCQ195
AT9311,LCQ-195 |
CDK | Cell Cycle/Checkpoint |
NVP-LCQ195 (LCQ-195) 是CDK 杂环类抑制剂,对CDK1,CDK2,CDK3和CDK5的IC50为1到42 nM 之间。 | |||
T2440 |
IC261
SU-5607 |
Apoptosis; Casein Kinase; CDK | Apoptosis; Cell Cycle/Checkpoint; Metabolism; Stem Cells |
IC261 (SU-5607) 是一种选择性的,ATP 竞争性的CK1抑制剂,可触发有丝分裂检查点控制。对Ckiδ、Ckiε、 Ckiα1 和Cdk5的IC50值分别为 1 μM、1 μM 、16 μM 和4.5mM。 | |||
T2095 |
Seliciclib
Roscovitine,R-roscovitine,CYC202 |
CDK | Cell Cycle/Checkpoint |
Seliciclib (Roscovitine) 是 Cdk2/cyclin E 的有效抑制剂,IC50为0.1 µM。它还抑制 Cdk7/cyclin H、Cdk5/p35 和 Cdc2/cyclin B,IC50为 0.49、0.16和0.65 µM。 | |||
T77341 |
GSK-3 inhibitor 4
|
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
GSK-3 inhibitor 4 是一种具有口服活性和脑渗透性的 GSK-3,CDK2 和 CDK5 三重抑制剂,对 GSK-3β,GSK-3α,CDK2 和 CDK5 具有抑制作用,IC50 值分别为 0.56 nM ,0.45 nM ,0.47 μM,0.68 μM。GSK-3 inhibitor 4 可有效降低 Tau protein 水平。GSK-3 inhibitor 4 可用于研究阿尔茨海默症 。 | |||
T2247 |
KenPaullone
9-Bromopaullone,NSC-664704,9-溴-7,12-二氢吲哚并[3,2-D][1]苯并氮杂卓-6(5H)-酮 |
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
KenPaullone (9-Bromopaullone) 是一种CDK1/cyclin B 和GSK-3β抑制剂,IC50值分别为 0.4 μM 和 23 nM。它也抑制 CDK2/cyclin A、CDK2/cyclin E 和 CDK5/p25 的活性,IC50值分别为 0.68 μM、7.5 μM 和 0.85 μM。。它通过增强 TGFβ-Smad3 信号通路增加和延长 foxp3 基因的转录来促进 iTreg 细胞分化。 | |||
T1917 |
GSK 3 Inhibitor IX
BIO,GSK 3 IX,6-BIO,6-Bromoindirubin-3'-oxime,MLS 2052,6-bromoindirubin-3-oxime |
Apoptosis; GSK-3; Tyrosine Kinases; CDK | Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
GSK 3 Inhibitor IX (6-BIO) 是一种选择性可逆的,ATP 竞争性的 GSK-3α/β和 CDK1-cyclinB 复合体抑制剂,能够抑制 (GSK-3α/β)/CDK1/CDK5 的活性,IC50值分别为 5 nM/320 nM/83 nM。 | |||
T1912 |
Dinaciclib
SCH 727965,PS-095760 |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
Dinaciclib (SCH 727965) 是一种 CDK 抑制剂,抑制 CDK1、CDK2、CDK5 和 CDK9 (IC50=3/1/1/4 nM),具有选择性。Dinaciclib 具有潜在的抗肿瘤活性,可以抑制胸甘 (dThd) DNA 的整合。 | |||
T5200 |
Indirubin-3'-monoxime
靛玉红-3' -单肟,Indirubin-3'-oxime |
GSK-3; Lipoxygenase; CDK | Cell Cycle/Checkpoint; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
Indirubin-3'-monoxime (Indirubin-3'-oxime) 是一种有效的 GSK3β 抑制剂,IC50值为 22 nM。它对 CDK5/p25、CDK1/cyclin B 和CDk2/cyclin E 也有作用,IC50值分别为 100、180 和 250 nM。 | |||
T6358 |
1-Azakenpaullone
1-氮杂坎帕罗酮,azakenpaullone |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
1-Azakenpaullone (azakenpaullone) 是一种 ATP 竞争性的、具有高度选择性的糖原合成酶激酶3 β (GSK-3β)的抑制剂,其 IC50=18 nM。 | |||
T36964 |
BML-259
CAY10554 |
CDK | Cell Cycle/Checkpoint |
BML-259 是 CDK5 和 CDK2 的抑制剂,IC50 分别为 64 和 98 nM。 BML-259 可用于癌症和神经退行性疾病治疗的研究。 | |||
T21588 |
Olomoucine
|
ERK; CDK | Cell Cycle/Checkpoint; MAPK |
Olomoucine 是 Cdk2/cyclin A、Cdc2/CyclinB、CDK2/CyclinE、CDK5/p35 和 ERK1/p44 MAP 激酶的 ATP 竞争性抑制剂,IC50 分别为 7、7、7、3 和 25 µM。 Olomoucine 调节细胞周期并表现出抗黑色素肿瘤活性。 | |||
T23389 |
SR1664
SR 1664 |
PPAR | DNA Damage/DNA Repair; Metabolism |
SR1664 是一种PPARγ拮抗剂,与结合PPARγ,可有效抑制 Cdk5 介导的PPARγ磷酸化,IC50为80 nM,Ki 为 28.67 nM。 | |||
T21720 |
GP-82996
Cdk4/6 Inhibitor IV,CINK4 |
CDK | Cell Cycle/Checkpoint |
GP-82996 (CINK4) (CINK4) 是 CDK4/6的药理学抑制剂。GP-82996 对 CDK4/cyclin D1、CDK6/cyclin D1 和 Cdk5/p35 的 IC50s 分别为 1.5、5.6 和 25 μM。GP-82996 诱导肿瘤细胞 U2OS 的凋亡,可用于癌症研究。 | |||
T6787 |
BIO-acetoxime
BIA,GSK-3 Inhibitor X |
Apoptosis; GSK-3; HSV | Apoptosis; Microbiology/Virology; PI3K/Akt/mTOR signaling; Stem Cells |
BIO-acetoxime (GSK-3 Inhibitor X) 是一种 GSK3α/β 抑制剂,IC50值均为 10 nM,具有抗惊厥和抗感染作用。 | |||
T2378 |
RGB-286638 free base
|
GSK-3; MEK; JAK; CDK | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells |
RGB-286638 free base 是一种新型 CDK 抑制剂,抑制cyclin T1-CDK9、cyclin B1-CDK1、cyclin E-CDK2、cyclin D1-CDK4、cyclin E-CDK3和p35-CDK5活性,IC50分别为 1、2、3、4、5 和 5 nM。它也抑制 GSK-3β、TAK1、Jak2 和 MEK1,IC50值分别为 3、5、50和 54 nM。 | |||
T61439 |
DSS30
|
Beta Amyloid; BACE; CDK | Cell Cycle/Checkpoint; Neuroscience |
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。 | |||
T22260 |
Aminopurvalanol A
|
CDK | Cell Cycle/Checkpoint |
Aminopurvalanol A 是一种竞争性、选择性和细胞渗透性的Cyclins/Cdk 复合物抑制剂,优先靶向G2/M 期转变进而抑制癌细胞分化。它通过抑制生理获能依赖性肌动蛋白聚合而抑制精子受精能力。 | |||
T6940 |
PHA-767491 hydrochloride
CAY10572,PHA-767491,PHA767491 HCl,CAY-10572 hydrochloride |
Apoptosis; GSK-3; CDK | Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
PHA-767491 hydrochloride (CAY-10572 hydrochloride) 是一种Cdc7-Dbf4(DDK)/Cdk9的双重抑制剂,IC50值分别为 10 nM 和 34 nM。 | |||
T10898 |
Samuraciclib hydrochloride
ICEC0942 hydrochloride,CT7001 hydrochloride |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
Samuraciclib hydrochloride (ICEC0942 hydrochloride) 是一种具有选择性,ATP 竞争性和口服活性的CDK7抑制剂,IC50为 41 nM。它以 GI50值为 0.2-0.3 µM 来抑制乳腺癌细胞系的生长,具有抗肿瘤作用。 | |||
T2506 |
AZD-5438
AZD5438 |
CDK | Cell Cycle/Checkpoint |
AZD-5438 有效抑制 CDK1,CDK2,CDK9,IC50值分别为 16 nM, 6 nM, 20 nM,但它对 GSK3β,CDK5,CDK6 的抑制作用较弱。 | |||
T2059 |
Purvalanol A
NG-60 |
Apoptosis; CDK; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint |
Purvalanol A (NG-60) 是一种CDK 抑制剂,对 cdc2-cyclin B、cdc2-cyclin B、cdk2-cyclin E、cdk4-cyclin D1 和 cdk5-p35 的IC50值分别为 4、70、35、850 和 75 nM。 | |||
T14943 |
CGP60474
|
VEGFR; CDK; PKC | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
CGP60474 是一种高效的抗内毒素药物,抑制细胞周期蛋白依赖激酶(CDK) ,抑制 CDK1/B、CDK2/E、CDK2/a、CDK4/D、CDK5/p25、CDK7/H 和 CDK9/T 的IC50分别为 26、3、4、216、10、200 和 13 nM。它是选择性和 ATP 竞争性PKC 抑制剂。 | |||
T10172 |
5-Iodo-indirubin-3'-monoxime
|
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
5-Iodo-indirubin-3'-monoxime 是一种 GSK-3β、CDK5/P25和CDK1/cyclin B 抑制剂,IC50值分别为 9、20 和 25 nM,与 ATP 竞争性地结合酶的催化位点。 | |||
T71486 |
NS-0011
|
||
NS-0011 is an inhibitor of CDK5 translocation which increases CDK5 accumulation in the nucleus, suppressing both cancer cell proliferation and xenograft tumorigenesis. | |||
T11652 |
Indirubin-3'-monoxime-5-sulphonic acid
|
Others | Others |
Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of GSK-3β, CDK5, and CDK1 with IC50s of 80nM,5 nM, and 7 nM, respectively. | |||
T22590 |
AT7519 TFA
AT7519 trifluoroacetate |
Others | Others |
AT7519 is a kinase inhibitor (IC50: 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 μM for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35). | |||
T21377 | Aloisine A | ||
Aloisine A is a potent and selective CDK/GSK-3 inhibitor. IC50 data of Aloisine A: Cdk1/cyclin B (IC50: 150nM), Cdk2/cyclin A (IC50: 120nM), Cdk2/cyclin E (IC50: 400nM), Cdk5/p25 (IC50: 200nM), Cdk5/p35 (IC50: 160nM), GSK-3α (IC50: 500nM), GSK-3β (IC50: 6 | |||
T24734 |
RP-106
RP 106 |
||
RP-106 is an ATP-competitive inhibitor of CDK5/p25, CDK1/cyclin B, and GSK-3. | |||
T25650 |
LDN-193665
LDN 193665,LDN193665 |
||
LDN-193665 is a potent inhibitor of tau kinase. It acts by targeting CDK5/p25 and GSK3β. | |||
T61890 |
(E/Z)-BIO-acetoxime
|
||
(E/Z)-BIO-acetoxime 是有效的,选择性的GSK-3α/β 抑制剂。对于GSK-3α/β,CDK5/p25,CDK2/cyclin A 和CDK1/cyclin B 的IC50分别为10nM,2.4μM, 4.3μM, 63μM。 | |||
T62554 | PPARγ phosphorylation inhibitor 1 | ||
PPARγ phosphorylation inhibitor 1 (Compound 10) 是一种有效的 PPARγ结合剂 (IC50: 24 nM),具有抗糖尿病效果。PPARγ phosphorylation inhibitor 1 对 CDK5 介导的 PPARγ Ser273 磷酸化表现出抑制作用 (IC50: 160 nM),且几乎无 PPARγ 激动作用。 | |||
T62694 |
(S)-GFB-12811
|
||
(S)-GFB-12811 (compound 596) 是一种选择性的、选择性的 CDK5 抑制剂 (IC50<10 nM)。(S)-GFB-12811 能够用于细胞周期进程、神经元发育、肿瘤发生的研究。 | |||
T60661 |
CP681301
|
||
CP681301 是CDK5的有效抑制剂,具有抗增殖活性。CP681301 在果蝇中表现出抗肿瘤活性。CP681301 降低神经胶质瘤干细胞中 CD133、OLIG2、SOX2、KI67、pCDK5 蛋白水平的表达。CP681301 减少小鼠胶质瘤异种移植物的自我更新。 | |||
T62695 |
GFB-12811
|
||
GFB-12811,一种具有高选择性的口服活性CDK5抑制剂,其IC50为2.3 nM。该化合物对其他CDK激酶(CDK1/2/6/7/9)表现出显著的选择性。 | |||
T11653 |
Indirubin-5-sulfonate
|
Others | Others |
Indirubin-5-sulfonate shows inhibitory activity against GSK-3β. Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, | |||
T63437 | CDK1-IN-5 | ||
CDK1-IN-5 (10h) 是一种选择性的 CDK1 抑制剂,能够作用于 CDK1 (IC50: 42.19 nM),CDK2 (IC50: 188.71 nM) 和 CDK5 (IC50: 354.15 nM)。CDK1-IN-5 能够影响细胞周期并抑制癌细胞生长,能够用于研究癌症。 | |||
T63080 | CDK1-IN-4 | ||
CDK1-IN-4 (10d) 是一种选择性的 CDK1 抑制剂,能够作用于 CDK1 (IC50: 44.52 nM)、CDK2 (IC50: 624.93 nM) 和 CDK5 (IC50: 135.22 nM)。CDK1-IN-4 能够影响细胞周期,进而对癌细胞的生长表现出抑制作用。CDK1-IN-4 能够用于研究癌症。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3673 |
Clausine Z
|
CDK | Cell Cycle/Checkpoint |
Clausine Z exhibits inhibitory activity against cyclin-dependent kinase 5 (CDK5) and shows protective effects on cerebellar granule neurons in vitro. | |||
T38441 |
Manzamine A hydrochloride
|
||
Manzamine A hydrochloride is an orally active beta-carboline alkaloid that exhibits specific inhibitory effects on GSK-3β (IC50 = 10.2 μM) and CDK-5 (IC50 = 1.5 μM). Additionally, it targets vacuolar ATPases, leading to the inhibition of autophagy in pancreatic cancer cells. Manzamine A hydrochloride possesses antimalarial and anticancer properties, and also demonstrates potent activity against HSV-1[4]. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01171 |
CDK5 Protein, Human, Recombinant
Serine/threonine-protein kinase PSSALRE,Cyclin-dependent-lik... |
Human | E. coli |
CDK5 Protein, Human, Recombinant is expressed in E. coli. | |||
TMPY-04556 |
CDK5 Protein, Human, Recombinant (GST)
PSSALRE,cyclin-dependent kinase 5 |
Human | Baculovirus Insect Cells |
Cell division protein kinase 5, also known as Cyclin-dependent kinase 5, Serine/threonine-protein kinase PSSALRE, Tau protein kinase II catalytic subunit, TPKII catalytic subunit and CDK5, is a cytoplasm protein which belongs to theprotein kinase superfamily, CMGC Ser/Thr protein kinase family and CDC2 / CDKX subfamily. Cyclin-dependent kinases (Cdks) are a family of proline-directed Ser/Thr kinases known for their role in the control of cell cycle progression. In 1992, this family was jo... | |||
TMPH-01170 |
CDK5R1 Protein, Human, Recombinant (His)
CDK5 activator 1,CDK5R,N... |
Human | E. coli |
CDK5R1 Protein, Human, Recombinant (His) is expressed in E. coli. | |||
TMPH-02683 |
GSTP1 Protein, Mouse, Recombinant (His & SUMO)
|
Mouse | E. coli |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration. | |||
TMPH-01399 |
GSTP1 Protein, Human, Recombinant (His)
|
Human | P. pastoris (Yeast) |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration. GSTP1 Protein, Human, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 25.2 kDa and... | |||
TMPH-01398 |
GSTP1 Protein, Human, Recombinant (E. coli, His)
|
Human | E. coli |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration. GSTP1 Protein, Human, Recombinant (E. coli, His) is expressed in E. coli expression system with N-10xHis tag. The predicted mo... | |||
TMPJ-00499 |
GSTP1 Protein, Human, Recombinant
GSTP1,GST3,GST class-pi,Glutathione S-transferase P,FAEES3,G... |
Human | E. coli |
Glutathione S-transferase P (GSTP1) is an enzyme that contains 1 GST C-terminal domain, 1 GST N-terminal domain. GSTP1 belongs to the GST superfamily, the GSTs are a family of enzymes that play an important role in detoxification by catalyzing the conjugation of many hydrophobic and electrophilic compounds with reduced glutathione. Based on their biochemical, immunologic, and structural properties, the soluble GSTs are categorized into 4 main classes: alpha, mu, pi, and theta. The glutathione ... |